These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15198566)

  • 1. Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design.
    Prakobvaitayakit M; Nimmannit U
    AAPS PharmSciTech; 2003 Dec; 4(4):E71. PubMed ID: 15198566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
    Zhou YZ; Alany RG; Chuang V; Wen J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
    Mainardes RM; Evangelista RC
    Int J Pharm; 2005 Feb; 290(1-2):137-44. PubMed ID: 15664139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
    Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
    Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
    Yadav KS; Sawant KK
    Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response surface methodology to obtain beta-estradiol biodegradable microspheres for long-term therapy of osteoporosis.
    Zaghloul AA; Mustafa F; Siddiqui A; Khan M
    Pharm Dev Technol; 2006; 11(3):377-87. PubMed ID: 16895848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design.
    Carraro TC; Khalil NM; Mainardes RM
    Pharm Dev Technol; 2016 Mar; 21(2):140-6. PubMed ID: 25384838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole-loaded poly(lactic-co-glycolic) acid nanoparticles for improved antifungal activity.
    Patel NR; Damann K; Leonardi C; Sabliov CM
    Nanomedicine (Lond); 2010 Sep; 5(7):1037-50. PubMed ID: 20874019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-encapsulation of human serum albumin and superparamagnetic iron oxide in PLGA nanoparticles: part II. Effect of process variables on protein model drug encapsulation efficiency.
    Shubhra QT; Feczkó T; Kardos AF; Tóth J; Mackova H; Horak D; Dósa G; Gyenis J
    J Microencapsul; 2014; 31(2):156-65. PubMed ID: 23875617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of N-Acetylcysteine-loaded poly (lactic-co-glycolic acid) nanoparticles by electrospray.
    Karimi Zarchi AA; Abbasi S; Faramarzi MA; Gilani K; Ghazi-Khansari M; Amani A
    Int J Biol Macromol; 2015 Jan; 72():764-70. PubMed ID: 25224287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity and toxicity of itraconazole in DMSA-PLGA nanoparticles.
    Cunha-Azevedo EP; Silva JR; Martins OP; Siqueira-Moura MP; Bocca AL; Felipe MS; Tedesco AC; Azevedo RB
    J Nanosci Nanotechnol; 2011 Mar; 11(3):2308-14. PubMed ID: 21449386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V; Sadoqi M; Shao J
    Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation.
    Van de Ven H; Vermeersch M; Matheeussen A; Vandervoort J; Weyenberg W; Apers S; Cos P; Maes L; Ludwig A
    Int J Pharm; 2011 Nov; 420(1):122-32. PubMed ID: 21864661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical analysis of low molecular mass heparin nanoencapsulation.
    Ganti V; Mengesha AE; Marszalek J; Youan BB
    Acta Pharm; 2010 Sep; 60(3):281-93. PubMed ID: 21134863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.